The history of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, producing billions in income, its patent expiration created a deluge of generic competition , significantly diminishing its dominance. While some firms may try to capitalize on related treatments , the existing landscape